TY - JOUR
T1 - Japanese guidelines for the management of palmoplantar keratoderma
AU - Committee on Guidelines for the Management of PPKs
AU - Yoneda, Kozo
AU - Kubo, Akiharu
AU - Nomura, Toshifumi
AU - Ishida-Yamamoto, Akemi
AU - Suga, Yasushi
AU - Akiyama, Masashi
AU - Kanazawa, Nobuo
AU - Hashimoto, Takashi
N1 - Funding Information:
The preparation of these guidelines was supported in part by the Ministry of Health, Labour and Welfare's Grant‐in‐Aid for Scientific Research issued to the Ministry of Health, Labour and Welfare Research Project, entitled: “Comprehensive research on rare and intractable diseases associated with skin genetics.”
Publisher Copyright:
© 2021 Japanese Dermatological Association
PY - 2021/8
Y1 - 2021/8
N2 - Palmoplantar keratoderma (PPK) is a collective term for keratinizing disorders in which the main clinical symptom is hyperkeratosis on the palms and soles. To establish the first Japanese guidelines approved by the Japanese Dermatological Association for the management of PPKs, the Committee for the Management of PPKs was founded as part of the Study Group for Rare Intractable Diseases. These guidelines aim to provide current information for the management of PPKs in Japan. Based on evidence, they summarize the clinical manifestations, pathophysiologies, diagnostic criteria, disease severity determination criteria, treatment, and treatment recommendations. Because of the rarity of PPKs, there are only few clinical studies with a high degree of evidence. Therefore, several parts of these guidelines were established based on the opinions of the committee. To further optimize the guidelines, periodic revision in line with new evidence is necessary.
AB - Palmoplantar keratoderma (PPK) is a collective term for keratinizing disorders in which the main clinical symptom is hyperkeratosis on the palms and soles. To establish the first Japanese guidelines approved by the Japanese Dermatological Association for the management of PPKs, the Committee for the Management of PPKs was founded as part of the Study Group for Rare Intractable Diseases. These guidelines aim to provide current information for the management of PPKs in Japan. Based on evidence, they summarize the clinical manifestations, pathophysiologies, diagnostic criteria, disease severity determination criteria, treatment, and treatment recommendations. Because of the rarity of PPKs, there are only few clinical studies with a high degree of evidence. Therefore, several parts of these guidelines were established based on the opinions of the committee. To further optimize the guidelines, periodic revision in line with new evidence is necessary.
KW - diagnostic algorithm
KW - palmoplantar keratoderma
KW - treatment
UR - http://www.scopus.com/inward/record.url?scp=85111089314&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111089314&partnerID=8YFLogxK
U2 - 10.1111/1346-8138.15850
DO - 10.1111/1346-8138.15850
M3 - Article
C2 - 34121213
AN - SCOPUS:85111089314
SN - 0385-2407
VL - 48
SP - e353-e367
JO - Journal of Dermatology
JF - Journal of Dermatology
IS - 8
ER -